World Journal of Pharmaceutical
and Medical Research

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN (O) : 2455-3301
ISSN (P) : 3051-2557
IMPACT FACTOR: 7.533

ICV : 78.6

World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , IFSIJ Measure of Journal Quality , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , Doi-Digital Online Identifier , ISSN National Centre , Zenodo Indexing , International CODEN Service, USA , 

SJIF Impact Factor: 7.533

Abstract

CHRONIC RHINOSINUSITIS (CRS): CURRENT CONCEPTS IN ETIOLOGY AND PATHOPHYSIOLOGY WITH NOVEL THERAPEUTIC APPROACHES

*Arya Chandran, Lekshmy Satheesh, Angela A. Thomas, Dr. Aneeta Toms

ABSTRACT

Chronic rhinosinusitis (CRS) is an inflammatory disease of the paranasal sinuses, which commonly results in chronic sinonasal symptoms. In the United States, 1% to 5% of the population has chronic rhinosinusitis. CRS is defined as 2 or more of 4 cardinal signs and symptoms (i.e., facial pain/pressure, hyposmia/anosmia, nasal discharge [anterior and/or posterior], nasal obstruction) irrespective of previous history of acute rhinosinusitis for a duration exceeding 12 consecutive weeks.[1]

[Full Text Article]    [Download Certificate]

Powered By WJPMR | All Right Reserved

WJPMR